17.96MMarket Cap-1.12P/E (TTM)
15.3500High13.2600Low51.30KVolume15.1100Open16.1300Pre Close708.81KTurnover6.61%Turnover RatioLossP/E (Static)1.32MShares22.320052wk High1.10P/B10.55MFloat Cap6.200052wk Low--Dividend TTM776.02KShs Float780.0000Historical High--Div YieldTTM12.96%Amplitude6.2000Historical Low13.8170Avg Price1Lot Size
Pieris Pharmaceuticals Stock Forum
3 MINUTES AGO, 7:30 AM EDT
VIA GLOBENEWSWIRE
FDA Orphan Products Grants are based on scientific and technical merit as determined by rare disease and regulatory experts
Ongoing Phase 3 trial evaluating QTORIN™ 3.9% rapamycin...
PRNewswire 24-Jul-2024 2:55 PM
This firm never misses a merger! Dont know if they do good work on not but Damn! Its every one! Hehehe
$Pieris Pharmaceuticals (PIRS.US)$
No comment yet